Ibuprofeno Braun

Ibuprofen, the active ingredient in Ibuprofeno Braun, is a Nonsteroidal anti-inflammatory drug (NSAID) presented as a intravenous solution for intravenous use. It treats mild to moderate pain, fever, inflammation, postoperative pain and musculoskeletal pain in adults.

GNH USA supplies Ibuprofeno Braun as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

Ibuprofeno Braun is an NSAID that reduces inflammation and pain through cyclooxygenase inhibition. - Mild to moderate pain: provides analgesia for acute and chronic pain conditions. - Fever: lowers elevated body temperature associated with infection or inflammation. - Inflammation: diminishes swelling in musculoskeletal and postoperative settings. - Post‑operative pain: manages pain after surgical procedures. - Musculoskeletal pain: alleviates discomfort from strains, sprains, and arthritis.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Dyspepsia: indigestion or stomach discomfort. - Headache: transient cranial pain. - Dizziness: occasional light‑headedness. - Injection site reactions: redness or mild swelling. - Transient renal function changes: slight increase in serum creatinine.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulcer perforation. - Severe renal failure or acute kidney injury. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Anaphylactic or severe allergic reactions. - Hepatic necrosis or severe liver injury. - Cardiovascular thrombotic events (rare).

Before initiating therapy, clinicians should evaluate patient‑specific risk factors. - Assess renal function: check baseline kidney parameters. - Monitor gastrointestinal risk: avoid in patients with active ulcers or bleeding disorders. - Avoid concomitant anticoagulants: increased bleeding potential. - Use with caution in asthma: may provoke bronchospasm. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Ibuprofeno Braun can alter the effect of several co‑administered medicines.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened bleeding risk. - Other NSAIDs: additive gastrointestinal toxicity. - Corticosteroids: increased ulceration potential. - SSRIs or SNRIs: amplified bleeding tendency. - ACE inhibitors in compromised renal function: risk of acute kidney injury.

Moderate Interactions (Monitor Closely): - Diuretics: may reduce renal perfusion. - Lithium: potential increase in serum lithium levels. - Methotrexate: reduced clearance leading to toxicity. - Cyclosporine: enhanced nephrotoxic effect. - Beta‑blockers: possible masking of tachycardia.